1. Home
  2. AMST vs MBIO Comparison

AMST vs MBIO Comparison

Compare AMST & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMST
  • MBIO
  • Stock Information
  • Founded
  • AMST 2017
  • MBIO 2015
  • Country
  • AMST United States
  • MBIO United States
  • Employees
  • AMST N/A
  • MBIO N/A
  • Industry
  • AMST Computer Software: Prepackaged Software
  • MBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMST Technology
  • MBIO Health Care
  • Exchange
  • AMST Nasdaq
  • MBIO Nasdaq
  • Market Cap
  • AMST 7.4M
  • MBIO 7.3M
  • IPO Year
  • AMST 2020
  • MBIO N/A
  • Fundamental
  • Price
  • AMST $3.29
  • MBIO $2.81
  • Analyst Decision
  • AMST
  • MBIO Strong Buy
  • Analyst Count
  • AMST 0
  • MBIO 1
  • Target Price
  • AMST N/A
  • MBIO $100.00
  • AVG Volume (30 Days)
  • AMST 109.2K
  • MBIO 410.6K
  • Earning Date
  • AMST 02-18-2025
  • MBIO 03-10-2025
  • Dividend Yield
  • AMST N/A
  • MBIO N/A
  • EPS Growth
  • AMST N/A
  • MBIO N/A
  • EPS
  • AMST N/A
  • MBIO N/A
  • Revenue
  • AMST $114,798.00
  • MBIO N/A
  • Revenue This Year
  • AMST N/A
  • MBIO N/A
  • Revenue Next Year
  • AMST N/A
  • MBIO N/A
  • P/E Ratio
  • AMST N/A
  • MBIO N/A
  • Revenue Growth
  • AMST N/A
  • MBIO N/A
  • 52 Week Low
  • AMST $1.85
  • MBIO $2.78
  • 52 Week High
  • AMST $6.27
  • MBIO $74.50
  • Technical
  • Relative Strength Index (RSI)
  • AMST 44.21
  • MBIO 28.00
  • Support Level
  • AMST $3.15
  • MBIO $3.96
  • Resistance Level
  • AMST $3.74
  • MBIO $6.70
  • Average True Range (ATR)
  • AMST 0.21
  • MBIO 0.97
  • MACD
  • AMST -0.00
  • MBIO -0.12
  • Stochastic Oscillator
  • AMST 24.62
  • MBIO 2.83

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: